DNA Barcoding in Nonhuman Primates Reveals Important Limitations in Retrovirus Integration Site Analysis

Area of Science:

• * Hematology and Gene Therapy
• * Stem Cell Biology
• * Molecular Biology

Background:

• * *In vivo* tracking of retrovirus-tagged blood stem and progenitor cells is essential for studying hematopoiesis.
• * Integration site analysis and retrovirus DNA barcode sequencing are primary methods for this tracking.
• * Integration site analysis is currently the sole method for monitoring clonal pools in patients receiving retrovirus-modified cells.

Purpose of the Study:

• * To compare the efficiency of integration site analysis and DNA barcode sequencing in detecting and quantifying clonal contributions.
• * To evaluate these methods in a clinically relevant nonhuman primate model of autologous transplantation.
• * To identify factors influencing the efficiency of each method and provide guidance for gene therapy applications.

Main Methods:

• * Simultaneous assessment of integration site analysis and DNA barcode sequencing in a nonhuman primate model.
• * Computational simulation to analyze the sources of low efficiency in integration site analysis.
• * Subsampling of different blood cell lineages at early time points post-transplantation.

Main Results:

• * Both methods successfully track abundant clones, but DNA barcode sequencing is at least 5-fold more efficient.
• * Computational simulations identified sampling depth as the primary factor limiting integration site analysis efficiency.
• * Integration site analysis requires prohibitive sampling depth for minimal clonal pool coverage, especially with low gene-modified cell engraftment.
• * Early subsampling of blood cell lineages provides valuable safety and hematopoietic biology insights.

Conclusions:

• * DNA barcode sequencing offers superior efficiency for tracking clonal contributions compared to integration site analysis.
• * Sampling depth is a critical limitation for integration site analysis in gene therapy monitoring.
• * DNA barcode sequencing can serve as a valuable guide for optimizing the interpretation of integration site analysis in clinical gene therapy.
• * Early lineage subsampling enhances the safety and biological understanding of gene therapy outcomes.